Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: a real-time PCR study.

Vignini A, Morganti S, Salvolini E, Sartini D, Luzzi S, Fiorini R, Provinciali L, Di Primio R, Mazzanti L, Emanuelli M.

Exp Gerontol. 2013 Dec;48(12):1505-8.

PMID:
24400342
2.

Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and Frontotemporal lobar degeneration: A Real-time PCR study.

Vignini A, Morganti S, Salvolini E, Sartini D, Luzzi S, Fiorini R, Provinciali L, Di Primio R, Mazzanti L, Emanuelli M.

Exp Gerontol. 2013 Oct 26. pii: S0531-5565(13)00312-4. doi: 10.1016/j.exger.2013.10.008. [Epub ahead of print]

PMID:
24513653
3.

Platelet amyloid precursor protein isoform expression in Alzheimer's disease: evidence for peripheral marker.

Vignini A, Sartini D, Morganti S, Nanetti L, Luzzi S, Provinciali L, Mazzanti L, Emanuelli M.

Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):529-34.

PMID:
21658330
4.

Expression of APP pathway mRNAs and proteins in Alzheimer's disease.

Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP, Irizarry MC, Hyman BT.

Brain Res. 2007 Aug 3;1161:116-23. Epub 2007 Jun 5.

PMID:
17586478
5.

Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease.

Di Luca M, Pastorino L, Bianchetti A, Perez J, Vignolo LA, Lenzi GL, Trabucchi M, Cattabeni F, Padovani A.

Arch Neurol. 1998 Sep;55(9):1195-200.

PMID:
9740113
6.

Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.

Panegyres PK, Zafiris-Toufexis K, Kakulas BA.

J Neurol Sci. 2000 Feb 15;173(2):81-92.

PMID:
10675649
7.

Amyloid precursor protein mRNA levels in Alzheimer's disease brain.

Preece P, Virley DJ, Costandi M, Coombes R, Moss SJ, Mudge AW, Jazin E, Cairns NJ.

Brain Res Mol Brain Res. 2004 Mar 17;122(1):1-9.

PMID:
14992810
8.

Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains.

Johnston JA, Norgren S, Ravid R, Wasco W, Winblad B, Lannfelt L, Cowburn RF.

Brain Res Mol Brain Res. 1996 Dec 31;43(1-2):85-95.

PMID:
9037522
9.

Coordinated increase of γ-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer's disease patients: quantitative analysis of p3-Alcα with a new ELISA system.

Konno T, Hata S, Hamada Y, Horikoshi-Sakuraba Y, Nakaya T, Saito Y, Yamamoto T, Yamamoto T, Maeda M, Ikeuchi T, Gandy S, Akatsu H, Suzuki T; Japanese Alzheimer's Disease Neuroimaging Initiative.

Mol Neurodegener. 2011 Nov 8;6:76. doi: 10.1186/1750-1326-6-76.

10.

Platelet APP isoform ratios correlate with declining cognition in AD.

Baskin F, Rosenberg RN, Iyer L, Hynan L, Cullum CM.

Neurology. 2000 May 23;54(10):1907-9.

PMID:
10822427
11.

Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.

Alexopoulos P, Ebert A, Richter-Schmidinger T, Schöll E, Natale B, Aguilar CA, Gourzis P, Weih M, Perneczky R, Diehl-Schmid J, Kneib T, Förstl H, Kurz A, Danek A, Kornhuber J.

Dement Geriatr Cogn Disord. 2010;29(5):448-56. doi: 10.1159/000312685. Epub 2010 May 26.

PMID:
20502019
12.

Does executive impairment define a frontal variant of Alzheimer's disease?

Woodward M, Brodaty H, Boundy K, Ames D, Blanch G, Balshaw R; PRIME Study Group.

Int Psychogeriatr. 2010 Dec;22(8):1280-90. doi: 10.1017/S1041610210001596. Epub 2010 Aug 19.

PMID:
20719041
13.

Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer's disease: evidence from the Frontal Behavioral Inventory.

Konstantinopoulou E, Aretouli E, Ioannidis P, Karacostas D, Kosmidis MH.

Int J Geriatr Psychiatry. 2013 Sep;28(9):939-46. doi: 10.1002/gps.3907. Epub 2012 Nov 7.

PMID:
23135894
14.

The effects of Alzheimer's disease, other dementias, and premortem course on beta-amyloid precursor protein messenger RNA in frontal cortex.

Harrison PJ, Barton AJ, Procter AW, Bowen DM, Pearson RC.

J Neurochem. 1994 Feb;62(2):635-44.

PMID:
8294927
15.

Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.

Moir RD, Lynch T, Bush AI, Whyte S, Henry A, Portbury S, Multhaup G, Small DH, Tanzi RE, Beyreuther K, Masters CL.

J Biol Chem. 1998 Feb 27;273(9):5013-9.

16.

Enhanced production of amyloid precursor protein mRNA by peripheral mononuclear blood cell in Alzheimer's disease.

Jiang S, Zhang M, Ren D, Tang G, Lin S, Qian Y, Zhang Y, Jiang K, Li F, Wang D.

Am J Med Genet B Neuropsychiatr Genet. 2003 Apr 1;118B(1):99-102.

PMID:
12627474
18.
19.

Molecular genetic analysis of the APP, PSEN1, and PSEN2 genes in Finnish patients with early-onset Alzheimer disease and frontotemporal lobar degeneration.

Krüger J, Moilanen V, Majamaa K, Remes AM.

Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):272-6. doi: 10.1097/WAD.0b013e318231e6c7.

PMID:
21959359
20.

Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.

Tang K, Hynan LS, Baskin F, Rosenberg RN.

J Neurol Sci. 2006 Jan 15;240(1-2):53-8. Epub 2005 Oct 26.

Supplemental Content

Support Center